Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Advances in Therapy|July 20, 2016
Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea TreatmentsMartin Steinhoff, Marc Vocanson, Johannes J Voegel, et al.Plos One|March 21, 2009
Oral probiotic control skin inflammation by acting on both effector and regulatory T cellsFeriel Hacini-Rachinel, Hanane Gheit, Jean-Benoit Le Luduec, et al.Inflammatory Bowel Diseases|August 20, 2010
Blockade of LTB(4) /BLT(1) pathway improves CD8(+) T-cell-mediated colitisStephane Nancey, Gilles Boschetti, Feriel Hacini, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2009
CD4+ T cells and Lactobacillus casei control relapsing colitis mediated by CD8+ T cellsFeriel Hacini-Rachinel, Stephane Nancey, Gilles Boschetti, et al.International Archives of Allergy and Immunology|June 7, 2014
Low-allergenic hydrolyzed egg induces oral tolerance in miceFeriel Hacini-Rachinel, Yvonne M Vissers, Rémi Doucet-Ladevéze, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2005
Anopheles mosquito bites activate cutaneous mast cells leading to a local inflammatory response and lymph node hyperplasiaChristian E Demeure, Karima Brahimi, Feriel Hacini, et al.Journal of Medicinal Chemistry|October 31, 2023
Design of a Supersoft Topical JAK Inhibitor, Which Is Effective in Human Skin but Rapidly Deactivated in BloodGebhard Thoma, Odile Decoret, Eric Vangrevelinghe, et al.FEMS Microbiology Ecology|October 28, 2011
Infant gut microbiota is protective against cow's milk allergy in mice despite immature ileal T-cell responseBertrand Rodriguez, Guenolée Prioult, Feriel Hacini-Rachinel, et al.The Journal of Allergy and Clinical Immunology|March 27, 2017
Intestinal dendritic cell licensing through Toll-like receptor 4 is required for oral tolerance in allergic contact dermatitisFeriel Hacini-Rachinel, Mercedes Gomez de Agüero, Reem Kanjarawi, et al.Bioorganic & Medicinal Chemistry Letters|February 2, 2024
Discovery of a novel series of selective macrocyclic PKCTheta inhibitorsStefano Crosignani, Sebastien Campos, Claire Bouix-Peter, et al.Pageof 2